The Venture Codex Logo

The Venture Codex

Petrichor

220 East 42nd Street, 37th / PH Floor, New York, NY, 10017, United States

Overview

Customized investment structures and support for healthcare.

Founded

2017

Deals · 12mo

0

Links

WebsiteLinkedIn

Stage focus

Series C

Geographic focus

Germany
Sweden
United Kingdom
United States

Sector focus

Health Care

Investment portfolio

9rounds
NAMEDATESIZE
Egetis Therapeutics
Oct 2025Participated
$19 MOther Equity
Geneoscopy
Jan 2025Participated
$105 MSeries C
Evergreen Theragnostics
Apr 2024Participated
$26 MOther Equity
Ascend Gene & Cell Therapies
May 2023Led
$133 MSeries A
Vero Biotech
Jan 2023Led
$30 MOther Equity
Palvella Therapeutics
Jan 2023Led
$38 MSeries D
Aurion Biotechnologies
Apr 2022Participated
$120 MSeries C
Leukocare
Jun 2021Led
$18 MOther Equity
Isotopen Technologien München
Apr 2021Led
$108 MOther Equity
Egetis Therapeutics
Oct 2025Participated
$19 MOther Equity
Geneoscopy
Jan 2025Participated
$105 MSeries C
Evergreen Theragnostics
Apr 2024Participated
$26 MOther Equity
Ascend Gene & Cell Therapies
May 2023Led
$133 MSeries A
Vero Biotech
Jan 2023Led
$30 MOther Equity
Palvella Therapeutics
Jan 2023Led
$38 MSeries D
Aurion Biotechnologies
Apr 2022Participated
$120 MSeries C
Leukocare
Jun 2021Led
$18 MOther Equity
Isotopen Technologien München
Apr 2021Led
$108 MOther Equity
9
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Petrichor: 9 funding rounds are recorded in the selected participation categories.All available history.
Petrichor: 9 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A10
Series C+12
Other Equity32

Monthly Deal Activity

Petrichor: 9 deals are recorded across 67 months.All available history.
Petrichor: 9 deals are recorded across 67 months. All available history
MonthDeals
Apr '211
May '210
Jun '211
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '221
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '232
Feb '230
Mar '230
Apr '230
May '231
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '241
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '251
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '251
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Petrichor: Health & Life Sciences is the largest displayed sector by deal count (9 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Petrichor: Health & Life Sciences is the largest displayed sector by deal count (9 deals). All available history
SectorDeals
Health & Life Sciences9
Manufacturing2
AI & Machine Learning1
Professional Services1

Deal Size Distribution

Petrichor: 9 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Petrichor: 9 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M2
$25M-$50M3
$50M-$100M0
$100M-$250M4
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Petrichor: United States has the largest recorded deal count among the displayed regions (5 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Petrichor: United States has the largest recorded deal count among the displayed regions (5 deals). All available history
RegionDeals
United States5
Europe4
Petrichor: 20 co-investors are shown, with Deerfield Management sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Petrichor: 20 co-investors are shown, with Deerfield Management sharing 2 recorded deals. All available history
Co-investorShared deals
Deerfield Management2
4BIO Capital1
Abingworth1
Agent Capital1
Ajinomoto1
Alcon1
Bio-Rad Laboratories1
BioAdvance1
BVF Partners1
Cathay Capital1
DCVC Bio1
Digitalis Ventures1
Falcon Vision1
Flying L Partners1
Frazier Life Sciences1
Gore Range Capital1
Granger Management1
Invus1
Labcorp1
LIFTT1

Investment Strategy

Petrichor: Led accounts for 56% and participating for 44% of round participation.All available history.
Petrichor: Led accounts for 56% and participating for 44% of round participation. All available history
CategoryDeals (count)Share (%)
Led556%
Participating444%
Petrichor: Single-lead accounts for 60% and co-led for 40% of lead dynamics.All available history.
Petrichor: Single-lead accounts for 60% and co-led for 40% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead360%
Co-led240%

Team

David Katona

Head of Business Development and Investor Relations

Michael Beecham

Partner

Patrick Lally

Partner

Tadd S. Wessel

Managing Partner